Legal Representation
Attorney
Scott Woldow
USPTO Deadlines
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 30, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| May 29, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 2, 2022 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Nov 1, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 1, 2022 | ICNA | I | NOTICE OF ALLOWANCE CORRECTION ENTERED | Loading... |
| Oct 19, 2022 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Sep 28, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 26, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 26, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 26, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 26, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 8, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 8, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 8, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 8, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 8, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 1, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 1, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 9, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 24, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 24, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 24, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 24, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 24, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jul 6, 2021 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 28, 2020 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Dec 13, 2019 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jun 6, 2019 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Dec 17, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 17, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 30, 2018 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Nov 7, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 20, 2018 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 20, 2018 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 20, 2018 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Mar 31, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 30, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 30, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 30, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 3, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 3, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 3, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 29, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 24, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 22, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
publication of texts, books, and magazines featuring the results of clinical trials for pharmaceutical preparations in the field of inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies, and A1P1 deficiency and emphysema; publication of printed matter relating to the results of clinical trials for pharmaceutical preparations for the treatment of A1P1 deficiency and emphysema
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
publication of texts, books, and magazines featuring the results of clinical trials for pharmaceutical preparations; publication of printed matter relating to the results of clinical trials for pharmaceutical preparations for the treatment of A1P1 deficiency and emphysema
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of inflammatory and immune system disorders and deficiencies, blood and bleeding disorders, inhibitors and antibody disorders and deficiencies, and A1P1 deficiencv and emphysema
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
041
042